Shares of Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) were down 0.4% during mid-day trading on Wednesday . The stock traded as low as $3.52 and last traded at $3.54. 7,479 shares were traded during trading, a decline of 44% from the average session volume of 13,389 shares. The stock had previously closed at $3.5550.
Medexus Pharmaceuticals Price Performance
The company has a fifty day moving average price of $3.25 and a two-hundred day moving average price of $2.73.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
